anisodamine has been researched along with Disease Models, Animal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; Liu, Y; Ouyang, Z; Qiu, Y; Shen, J; Wan, F; Zeng, Y; Zhong, J | 1 |
| Du, X; He, X; Liu, H; Wan, F; Zeng, Y | 1 |
| Chen, C; Wang, C; Yuan, X; Zheng, Y | 1 |
| Huan, G; Ke, P; Liu, C; Shao, BZ; Zhou, JX | 1 |
| Cui, WY; Huang, JH; Ning, M; Wang, H; Zhang, YF | 1 |
| Cheng, YQ; Dong, WZ; Lin, LL; Liu, AJ; Qian, J; Su, DF; Zhang, JM | 1 |
| Chen, W; Liu, XH; Meng, FS; Shen, H; Sun, J | 1 |
| Chen, W; Ji, D; Jia, LJ; Liu, XH; Shen, H; Zhao, XM | 1 |
| Jing, YL; Kong, XY; Li, HJ; Sun, Y; Wang, YL; Zhao, CX | 1 |
| Chen, HZ; Cui, YY; Hou, LN; Wang, H; Xia, Z; Xu, ZP; Zhu, L | 1 |
| Shen, H; Yang, Y; Yin, XL; Zhang, W | 1 |
| Fan, HM; Guo, JH; Kong, X; Liu, ZM; Wang, JY; Zhao, SG | 1 |
| Hock, CE; Lefer, AM; Su, J | 1 |
| He, L; Liu, J; Zhang, S | 1 |
| Chen, ZT | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
16 other study(ies) available for anisodamine and Disease Models, Animal
| Article | Year |
|---|---|
Anisodamine hydrobromide attenuates oxidative stress and proinflammatory cytokines in septic rats induced by cecal ligation and puncture.
Topics: Animals; Atropine Derivatives; Cytokines; Disease Models, Animal; Interleukin-6; Ligation; Oxidative Stress; Punctures; Rats; Sepsis; Shock, Septic; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
Protective effect of anisodamine hydrobromide on lipopolysaccharide-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Cell Line; Cytokines; Disease Models, Animal; Epithelial Cells; Glycolysis; Humans; Inflammation Mediators; Kidney; Lipopolysaccharides; Male; Mitochondria; Oxidative Stress; Protective Agents; Rats; Sepsis; Solanaceous Alkaloids | 2020 |
Anisodamine inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in rhabdomyolysis-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; CARD Signaling Adaptor Proteins; Carrier Proteins; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression; Inflammasomes; Interleukins; Male; Mice; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Rhabdomyolysis; Solanaceous Alkaloids; Thioredoxins | 2017 |
Combined treatment with anisodamine and neostigmine inhibits joint inflammation in collagen-induced arthritis mice.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen; Disease Models, Animal; Drug Therapy, Combination; Immunoglobulin G; Joints; Mice; Mice, Inbred DBA; Neostigmine; Solanaceous Alkaloids | 2014 |
[Novel drug composition ameliorating thrombosis and its molecular mechanisms].
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Disease Models, Animal; In Vitro Techniques; Male; Prazosin; Rats; Rats, Wistar; Solanaceous Alkaloids; Thrombosis | 2014 |
A combination of neostigmine and anisodamine protects against ischemic stroke by activating α7nAChR.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Cell Line, Transformed; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Knockout; Neostigmine; Nervous System Diseases; Neuroprostanes; Protein Binding; Random Allocation; Rats; Solanaceous Alkaloids; Time Factors | 2015 |
[The influence of anisodamine on cardiopulmonary resuscitation in rat].
Topics: Animals; Cardiopulmonary Resuscitation; Disease Models, Animal; Epinephrine; Female; Heart Arrest; Male; Rats; Rats, Sprague-Dawley; Solanaceous Alkaloids | 2008 |
[Effects of anisodamine on microcirculation of the asystole rats during the cardiopulmonary resuscitation].
Topics: Animals; Cardiopulmonary Resuscitation; Disease Models, Animal; Epinephrine; Heart Arrest; Microcirculation; Random Allocation; Rats; Rats, Wistar; Solanaceous Alkaloids | 2008 |
[Experimental research of prevention and therapy effect of anisodamine on acute respiratory distress syndrome (ARDS)].
Topics: Animals; Disease Models, Animal; Female; Free Radical Scavengers; Lipid Peroxidation; Male; Oleic Acid; Rabbits; Random Allocation; Respiratory Distress Syndrome; Solanaceous Alkaloids | 2009 |
Modulatory effect of anisodamine on airway hyper-reactivity and eosinophilic inflammation in a murine model of allergic asthma.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophils; Isometric Contraction; Leukocyte Count; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Respiratory System; Solanaceous Alkaloids | 2011 |
Inhibition of endoplasm reticulum stress by anisodamine protects against myocardial injury after cardiac arrest and resuscitation in rats.
Topics: Animals; Apoptosis; Cardiopulmonary Resuscitation; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heart Arrest; Heart Injuries; Humans; Male; Myocardium; Random Allocation; Rats; Reperfusion Injury; Solanaceous Alkaloids | 2011 |
[Anisodamine inhalation ameliorates rat acute lung injury caused by oleic acid].
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Disease Models, Animal; Lung; Male; Oleic Acid; Random Allocation; Rats; Rats, Sprague-Dawley; Solanaceous Alkaloids | 2008 |
Beneficial effect of anisodamine in hemorrhagic shock.
Topics: Animals; Blood Pressure; Cathepsin D; Cathepsins; Cats; Disease Models, Animal; In Vitro Techniques; Infusions, Parenteral; Male; Mesenteric Arteries; Myocardial Depressant Factor; Pancreas; Peptides; Regional Blood Flow; Shock, Hemorrhagic; Solanaceous Alkaloids; Vasodilator Agents | 1984 |
[Anisodamine (654-2) improves impaired cognitive function induced by experimental brain damage].
Topics: Animals; Brain Ischemia; Cognition; Dementia; Disease Models, Animal; Female; Free Radical Scavengers; Learning Disabilities; Memory Disorders; Rats; Rats, Wistar; Solanaceous Alkaloids; Vasodilator Agents | 1995 |
[Canine model of respiratory distress syndrome induced by bone marrow extraction and pathological observation of the lung tissue].
Topics: Animals; Bone Marrow; Disease Models, Animal; Dogs; Respiratory Distress Syndrome; Solanaceous Alkaloids; Tissue Extracts; Vasodilator Agents | 1988 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |